Before ye go off spouting dumb shite it would behoove ye to educate yerself as to why that is.
The cost of repurposing drugs in Asia is prohibitive and as such the biotechs there choose not to invest their limited cash into such speculative ventures.
A whole paper was written on the subject and explains it all quite simply so that even lazy louts could understand. lololsss
News 
Market Data 
Discover 
